Abstract
Klebsiella pneumoniae is a bacterial pathogen that is increasingly responsible for hospital-acquired pneumonia and sepsis. Progressive development of antibiotic resistance has led to higher mortality rates and creates a need for novel treatments. Because of the essential role that nucleotides play in many bacterial processes, enzymes involved in purine and pyrimidine metabolism and transport are ideal targets for the development of novel antibiotics. Herein we describe the structure of K. pneumoniae adenosine monophosphate nucleosidase (KpAmn), a purine salvage enzyme unique to bacteria, as determined by cryoelectron microscopy. The data detail a well conserved fold with a hexameric overall structure and clear density for the putative active site residues. Comparison to the crystal structures of homologous prokaryotic proteins confirms the presence of many of the conserved structural features of this protein yet reveals differences in distal loops in the absence of crystal contacts. This first cryo-EM structure of an Amn enzyme provides a basis for future structure-guided drug development and extends the accuracy of structural characterization of this family of proteins beyond this clinically relevant organism.
Funder
National Institute of General Medical Sciences
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
Publisher
Public Library of Science (PLoS)
Reference38 articles.
1. Klebsiella pneumoniae: Going on the Offense with a Strong Defense;MK Paczosa;Microbiol Mol Biol Rev
2. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods;C-R Lee;Front Microbiol,2016
3. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review;MS Mulani;Front Microbiol.,2019
4. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies;Z Pang;Biotechnol Adv,2019
5. Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus;Y Guo;Front Cell Infect Microbiol,2020